The global Dread Disease Insurance market size was valued at US$ 26420 million in 2024 and is forecast to a readjusted size of USD 69790 million by 2031 with a CAGR of 15.1% during review period.
Dread Disease Insurance, also known as critical illness insurance, provides a lump sum payment in the event the insured is diagnosed with a specified serious illness, such as cancer or heart disease.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents鈥� wealth and the improvement of health awareness will drive the demand for medicines.
This report is a detailed and comprehensive analysis for global Dread Disease Insurance market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Dread Disease Insurance market size and forecasts, in consumption value ($ Million), 2020-2031
Global Dread Disease Insurance market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Dread Disease Insurance market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Dread Disease Insurance market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Dread Disease Insurance
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Dread Disease Insurance market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Aegon, Aflac, AIG, Allianz, Aviva, AXA, China Life Insurance, China Pacific Insurance, Dai-ichi Life Group, Generali Group, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 segmentation
Dread Disease Insurance market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
Fixed-term Insurance
Whole-life Insurance
麻豆原创 segment by Application
Below 30 Years Old
30-40 Years Old
41-50 Years Old
Above 50 Years Old
麻豆原创 segment by players, this report covers
Aegon
Aflac
AIG
Allianz
Aviva
AXA
China Life Insurance
China Pacific Insurance
Dai-ichi Life Group
Generali Group
HCF
Legal & General
Liberty Mutual
MetLife
New China Life Insurance
Ping An Insurance
Prudential plc
Royal London
Sun Life Financial
UnitedHealthcare
Zurich
麻豆原创 segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Dread Disease Insurance product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Dread Disease Insurance, with revenue, gross margin, and global market share of Dread Disease Insurance from 2020 to 2025.
Chapter 3, the Dread Disease Insurance competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Dread Disease Insurance market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Dread Disease Insurance.
Chapter 13, to describe Dread Disease Insurance research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 Classification of Dread Disease Insurance by Type
1.3.1 Overview: Global Dread Disease Insurance 麻豆原创 Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Dread Disease Insurance Consumption Value 麻豆原创 Share by Type in 2024
1.3.3 Fixed-term Insurance
1.3.4 Whole-life Insurance
1.4 Global Dread Disease Insurance 麻豆原创 by Application
1.4.1 Overview: Global Dread Disease Insurance 麻豆原创 Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Below 30 Years Old
1.4.3 30-40 Years Old
1.4.4 41-50 Years Old
1.4.5 Above 50 Years Old
1.5 Global Dread Disease Insurance 麻豆原创 Size & Forecast
1.6 Global Dread Disease Insurance 麻豆原创 Size and Forecast by Region
1.6.1 Global Dread Disease Insurance 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Dread Disease Insurance 麻豆原创 Size by Region, (2020-2031)
1.6.3 North America Dread Disease Insurance 麻豆原创 Size and Prospect (2020-2031)
1.6.4 Europe Dread Disease Insurance 麻豆原创 Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Dread Disease Insurance 麻豆原创 Size and Prospect (2020-2031)
1.6.6 South America Dread Disease Insurance 麻豆原创 Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Dread Disease Insurance 麻豆原创 Size and Prospect (2020-2031)
2 Company Profiles
2.1 Aegon
2.1.1 Aegon Details
2.1.2 Aegon Major Business
2.1.3 Aegon Dread Disease Insurance Product and Solutions
2.1.4 Aegon Dread Disease Insurance Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.1.5 Aegon Recent Developments and Future Plans
2.2 Aflac
2.2.1 Aflac Details
2.2.2 Aflac Major Business
2.2.3 Aflac Dread Disease Insurance Product and Solutions
2.2.4 Aflac Dread Disease Insurance Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.2.5 Aflac Recent Developments and Future Plans
2.3 AIG
2.3.1 AIG Details
2.3.2 AIG Major Business
2.3.3 AIG Dread Disease Insurance Product and Solutions
2.3.4 AIG Dread Disease Insurance Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.3.5 AIG Recent Developments and Future Plans
2.4 Allianz
2.4.1 Allianz Details
2.4.2 Allianz Major Business
2.4.3 Allianz Dread Disease Insurance Product and Solutions
2.4.4 Allianz Dread Disease Insurance Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.4.5 Allianz Recent Developments and Future Plans
2.5 Aviva
2.5.1 Aviva Details
2.5.2 Aviva Major Business
2.5.3 Aviva Dread Disease Insurance Product and Solutions
2.5.4 Aviva Dread Disease Insurance Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.5.5 Aviva Recent Developments and Future Plans
2.6 AXA
2.6.1 AXA Details
2.6.2 AXA Major Business
2.6.3 AXA Dread Disease Insurance Product and Solutions
2.6.4 AXA Dread Disease Insurance Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.6.5 AXA Recent Developments and Future Plans
2.7 China Life Insurance
2.7.1 China Life Insurance Details
2.7.2 China Life Insurance Major Business
2.7.3 China Life Insurance Dread Disease Insurance Product and Solutions
2.7.4 China Life Insurance Dread Disease Insurance Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.7.5 China Life Insurance Recent Developments and Future Plans
2.8 China Pacific Insurance
2.8.1 China Pacific Insurance Details
2.8.2 China Pacific Insurance Major Business
2.8.3 China Pacific Insurance Dread Disease Insurance Product and Solutions
2.8.4 China Pacific Insurance Dread Disease Insurance Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.8.5 China Pacific Insurance Recent Developments and Future Plans
2.9 Dai-ichi Life Group
2.9.1 Dai-ichi Life Group Details
2.9.2 Dai-ichi Life Group Major Business
2.9.3 Dai-ichi Life Group Dread Disease Insurance Product and Solutions
2.9.4 Dai-ichi Life Group Dread Disease Insurance Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.9.5 Dai-ichi Life Group Recent Developments and Future Plans
2.10 Generali Group
2.10.1 Generali Group Details
2.10.2 Generali Group Major Business
2.10.3 Generali Group Dread Disease Insurance Product and Solutions
2.10.4 Generali Group Dread Disease Insurance Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.10.5 Generali Group Recent Developments and Future Plans
2.11 HCF
2.11.1 HCF Details
2.11.2 HCF Major Business
2.11.3 HCF Dread Disease Insurance Product and Solutions
2.11.4 HCF Dread Disease Insurance Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.11.5 HCF Recent Developments and Future Plans
2.12 Legal & General
2.12.1 Legal & General Details
2.12.2 Legal & General Major Business
2.12.3 Legal & General Dread Disease Insurance Product and Solutions
2.12.4 Legal & General Dread Disease Insurance Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.12.5 Legal & General Recent Developments and Future Plans
2.13 Liberty Mutual
2.13.1 Liberty Mutual Details
2.13.2 Liberty Mutual Major Business
2.13.3 Liberty Mutual Dread Disease Insurance Product and Solutions
2.13.4 Liberty Mutual Dread Disease Insurance Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.13.5 Liberty Mutual Recent Developments and Future Plans
2.14 MetLife
2.14.1 MetLife Details
2.14.2 MetLife Major Business
2.14.3 MetLife Dread Disease Insurance Product and Solutions
2.14.4 MetLife Dread Disease Insurance Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.14.5 MetLife Recent Developments and Future Plans
2.15 New China Life Insurance
2.15.1 New China Life Insurance Details
2.15.2 New China Life Insurance Major Business
2.15.3 New China Life Insurance Dread Disease Insurance Product and Solutions
2.15.4 New China Life Insurance Dread Disease Insurance Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.15.5 New China Life Insurance Recent Developments and Future Plans
2.16 Ping An Insurance
2.16.1 Ping An Insurance Details
2.16.2 Ping An Insurance Major Business
2.16.3 Ping An Insurance Dread Disease Insurance Product and Solutions
2.16.4 Ping An Insurance Dread Disease Insurance Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.16.5 Ping An Insurance Recent Developments and Future Plans
2.17 Prudential plc
2.17.1 Prudential plc Details
2.17.2 Prudential plc Major Business
2.17.3 Prudential plc Dread Disease Insurance Product and Solutions
2.17.4 Prudential plc Dread Disease Insurance Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.17.5 Prudential plc Recent Developments and Future Plans
2.18 Royal London
2.18.1 Royal London Details
2.18.2 Royal London Major Business
2.18.3 Royal London Dread Disease Insurance Product and Solutions
2.18.4 Royal London Dread Disease Insurance Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.18.5 Royal London Recent Developments and Future Plans
2.19 Sun Life Financial
2.19.1 Sun Life Financial Details
2.19.2 Sun Life Financial Major Business
2.19.3 Sun Life Financial Dread Disease Insurance Product and Solutions
2.19.4 Sun Life Financial Dread Disease Insurance Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.19.5 Sun Life Financial Recent Developments and Future Plans
2.20 UnitedHealthcare
2.20.1 UnitedHealthcare Details
2.20.2 UnitedHealthcare Major Business
2.20.3 UnitedHealthcare Dread Disease Insurance Product and Solutions
2.20.4 UnitedHealthcare Dread Disease Insurance Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.20.5 UnitedHealthcare Recent Developments and Future Plans
2.21 Zurich
2.21.1 Zurich Details
2.21.2 Zurich Major Business
2.21.3 Zurich Dread Disease Insurance Product and Solutions
2.21.4 Zurich Dread Disease Insurance Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.21.5 Zurich Recent Developments and Future Plans
3 麻豆原创 Competition, by Players
3.1 Global Dread Disease Insurance Revenue and Share by Players (2020-2025)
3.2 麻豆原创 Share Analysis (2024)
3.2.1 麻豆原创 Share of Dread Disease Insurance by Company Revenue
3.2.2 Top 3 Dread Disease Insurance Players 麻豆原创 Share in 2024
3.2.3 Top 6 Dread Disease Insurance Players 麻豆原创 Share in 2024
3.3 Dread Disease Insurance 麻豆原创: Overall Company Footprint Analysis
3.3.1 Dread Disease Insurance 麻豆原创: Region Footprint
3.3.2 Dread Disease Insurance 麻豆原创: Company Product Type Footprint
3.3.3 Dread Disease Insurance 麻豆原创: Company Product Application Footprint
3.4 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 麻豆原创 Size Segment by Type
4.1 Global Dread Disease Insurance Consumption Value and 麻豆原创 Share by Type (2020-2025)
4.2 Global Dread Disease Insurance 麻豆原创 Forecast by Type (2026-2031)
5 麻豆原创 Size Segment by Application
5.1 Global Dread Disease Insurance Consumption Value 麻豆原创 Share by Application (2020-2025)
5.2 Global Dread Disease Insurance 麻豆原创 Forecast by Application (2026-2031)
6 North America
6.1 North America Dread Disease Insurance Consumption Value by Type (2020-2031)
6.2 North America Dread Disease Insurance 麻豆原创 Size by Application (2020-2031)
6.3 North America Dread Disease Insurance 麻豆原创 Size by Country
6.3.1 North America Dread Disease Insurance Consumption Value by Country (2020-2031)
6.3.2 United States Dread Disease Insurance 麻豆原创 Size and Forecast (2020-2031)
6.3.3 Canada Dread Disease Insurance 麻豆原创 Size and Forecast (2020-2031)
6.3.4 Mexico Dread Disease Insurance 麻豆原创 Size and Forecast (2020-2031)
7 Europe
7.1 Europe Dread Disease Insurance Consumption Value by Type (2020-2031)
7.2 Europe Dread Disease Insurance Consumption Value by Application (2020-2031)
7.3 Europe Dread Disease Insurance 麻豆原创 Size by Country
7.3.1 Europe Dread Disease Insurance Consumption Value by Country (2020-2031)
7.3.2 Germany Dread Disease Insurance 麻豆原创 Size and Forecast (2020-2031)
7.3.3 France Dread Disease Insurance 麻豆原创 Size and Forecast (2020-2031)
7.3.4 United Kingdom Dread Disease Insurance 麻豆原创 Size and Forecast (2020-2031)
7.3.5 Russia Dread Disease Insurance 麻豆原创 Size and Forecast (2020-2031)
7.3.6 Italy Dread Disease Insurance 麻豆原创 Size and Forecast (2020-2031)
8 Asia-Pacific
8.1 Asia-Pacific Dread Disease Insurance Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Dread Disease Insurance Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Dread Disease Insurance 麻豆原创 Size by Region
8.3.1 Asia-Pacific Dread Disease Insurance Consumption Value by Region (2020-2031)
8.3.2 China Dread Disease Insurance 麻豆原创 Size and Forecast (2020-2031)
8.3.3 Japan Dread Disease Insurance 麻豆原创 Size and Forecast (2020-2031)
8.3.4 South Korea Dread Disease Insurance 麻豆原创 Size and Forecast (2020-2031)
8.3.5 India Dread Disease Insurance 麻豆原创 Size and Forecast (2020-2031)
8.3.6 Southeast Asia Dread Disease Insurance 麻豆原创 Size and Forecast (2020-2031)
8.3.7 Australia Dread Disease Insurance 麻豆原创 Size and Forecast (2020-2031)
9 South America
9.1 South America Dread Disease Insurance Consumption Value by Type (2020-2031)
9.2 South America Dread Disease Insurance Consumption Value by Application (2020-2031)
9.3 South America Dread Disease Insurance 麻豆原创 Size by Country
9.3.1 South America Dread Disease Insurance Consumption Value by Country (2020-2031)
9.3.2 Brazil Dread Disease Insurance 麻豆原创 Size and Forecast (2020-2031)
9.3.3 Argentina Dread Disease Insurance 麻豆原创 Size and Forecast (2020-2031)
10 Middle East & Africa
10.1 Middle East & Africa Dread Disease Insurance Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Dread Disease Insurance Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Dread Disease Insurance 麻豆原创 Size by Country
10.3.1 Middle East & Africa Dread Disease Insurance Consumption Value by Country (2020-2031)
10.3.2 Turkey Dread Disease Insurance 麻豆原创 Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Dread Disease Insurance 麻豆原创 Size and Forecast (2020-2031)
10.3.4 UAE Dread Disease Insurance 麻豆原创 Size and Forecast (2020-2031)
11 麻豆原创 Dynamics
11.1 Dread Disease Insurance 麻豆原创 Drivers
11.2 Dread Disease Insurance 麻豆原创 Restraints
11.3 Dread Disease Insurance Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Dread Disease Insurance Industry Chain
12.2 Dread Disease Insurance Upstream Analysis
12.3 Dread Disease Insurance Midstream Analysis
12.4 Dread Disease Insurance Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Aegon
Aflac
AIG
Allianz
Aviva
AXA
China Life Insurance
China Pacific Insurance
Dai-ichi Life Group
Generali Group
HCF
Legal & General
Liberty Mutual
MetLife
New China Life Insurance
Ping An Insurance
Prudential plc
Royal London
Sun Life Financial
UnitedHealthcare
Zurich
听
听
*If Applicable.